CMPD101
CMPD101 is a potent, highly selective and membrane-permeable small-molecule inhibitor of GRK2/3 with IC50 of 18 nM and 5.4 nM, respectively. CMPD101 exhibits less selectively against GRK1, GRK5, ROCK-2 and PKCα with IC50s of 3.1 μM , 2.3 μM, 1.4 μM and 8.1 μM, respectively. CMPD101 can be used for the study of heart failure[1].
Product Specifications
CAS Number
865608-11-3
UNSPSC
12352005
Target
G Protein-coupled Receptor Kinase (GRK) ; PKC; ROCK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton; Epigenetics; GPCR/G Protein; Stem Cell/Wnt; TGF-beta/Smad
Applications
COVID-19-anti-virus
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/cmpd101.html
Concentration
10mM
Purity
98.95
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(C1=CC(NCC2=NN=C(C3=CC=NC=C3)N2C)=CC=C1)NCC4=CC=CC=C4C(F)(F)F
Molecular Formula
C24H21F3N6O
Molecular Weight
466.46
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
GRK2; PKCα; ROCK2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
EDN1, CT (EDN1, Endothelin-1, Preproendothelin-1, Big endothelin-1) (AP) discontinued
FLT3 (FMS-related Tyrosine Kinase 3, CD135, FLK2, STK1) (FITC)
FLT3 (FMS-related Tyrosine Kinase 3, CD135, FLK2, STK1) (FITC)
